» Articles » PMID: 34903738

Nuclear Pore Protein NUP210 Depletion Suppresses Metastasis Through Heterochromatin-mediated Disruption of Tumor Cell Mechanical Response

Abstract

Mechanical signals from the extracellular microenvironment have been implicated in tumor and metastatic progression. Here, we identify nucleoporin NUP210 as a metastasis susceptibility gene for human estrogen receptor positive (ER+) breast cancer and a cellular mechanosensor. Nup210 depletion suppresses lung metastasis in mouse models of breast cancer. Mechanistically, NUP210 interacts with LINC complex protein SUN2 which connects the nucleus to the cytoskeleton. In addition, the NUP210/SUN2 complex interacts with chromatin via the short isoform of BRD4 and histone H3.1/H3.2 at the nuclear periphery. In Nup210 knockout cells, mechanosensitive genes accumulate H3K27me3 heterochromatin modification, mediated by the polycomb repressive complex 2 and differentially reposition within the nucleus. Transcriptional repression in Nup210 knockout cells results in defective mechanotransduction and focal adhesion necessary for their metastatic capacity. Our study provides an important role of nuclear pore protein in cellular mechanosensation and metastasis.

Citing Articles

Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis.

Liu Z, Liu Y, Kang X, Li L, Xiang Y Pharmaceutics. 2025; 17(2).

PMID: 40006565 PMC: 11859411. DOI: 10.3390/pharmaceutics17020198.


Transcriptomic-Based Identification of miR-125a Novel Targets in Human Hepatocarcinoma Cells.

De Leo I, Mosca N, Pezzullo M, Valletta D, Manfrevola F, Mele V Biomolecules. 2025; 15(1).

PMID: 39858538 PMC: 11763984. DOI: 10.3390/biom15010144.


The Potential of Nuclear Pore Complexes in Cancer Therapy.

Zaitsava H, Gachowska M, Bartoszewska E, Kmiecik A, Kulbacka J Molecules. 2024; 29(20).

PMID: 39459201 PMC: 11510365. DOI: 10.3390/molecules29204832.


Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer.

Kashyap V, Nagesh P, Singh A, Massey A, Darkwah G, George A Cancer Cell Int. 2024; 24(1):343.

PMID: 39428480 PMC: 11492755. DOI: 10.1186/s12935-024-03513-z.


SMARCD1 is an essential expression-restricted metastasis modifier.

Ross C, Gong L, Jenkins L, Ha N, Majocha M, Hunter K Commun Biol. 2024; 7(1):1299.

PMID: 39390150 PMC: 11467182. DOI: 10.1038/s42003-024-07018-3.


References
1.
Hunter K, Amin R, Deasy S, Ha N, Wakefield L . Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer. 2018; 18(4):211-223. PMC: 6290469. DOI: 10.1038/nrc.2017.126. View

2.
Nguyen D, Bos P, Massague J . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9(4):274-84. DOI: 10.1038/nrc2622. View

3.
Sethi N, Kang Y . Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer. 2011; 11(10):735-48. PMC: 10961136. DOI: 10.1038/nrc3125. View

4.
Steeg P . Targeting metastasis. Nat Rev Cancer. 2016; 16(4):201-18. PMC: 7055530. DOI: 10.1038/nrc.2016.25. View

5.
Ross C, Szczepanek K, Lee M, Yang H, Qiu T, Sanford J . The genomic landscape of metastasis in treatment-naïve breast cancer models. PLoS Genet. 2020; 16(5):e1008743. PMC: 7282675. DOI: 10.1371/journal.pgen.1008743. View